News
Molecular breast imaging company Gamma Medica, Inc. is expanding the capabilities of its LumaGEM Molecular Breast Imaging (MBI) System with a biopsy accessory. Gamma Medica’s technology clearly lights up tumors, even those obscured by dense breast tissue. This new LumaGUIDE hardware and software package, currently a work-in-progress, will allow physicians to precisely identify and biopsy suspicious lesions. The new procedure is quick (about half the time of an MRI-guided biopsy), easy-to-use, and streamlined.
January 16, 2013 
News
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced the completion of a study of its novel radiopharmaceutical NAV4694 as a biomarker for visual detection and quantification of cerebral ?-amyloid in diagnosing Alzheimer’s disease (AD). The study was designed and conducted by Navidea’s partner, AstraZeneca, to assess the effects of various mass amounts of AZD4694 (NAV4694) on safety and the efficacy of positron emission tomography (PET) scanning in subjects with AD and in healthy volunteers (HVs). Evaluations were completed on the effects of two mass doses of the radioligand on binding parameters and overall image quality. These endpoints are typical and important requirements of drug registration dossiers filed with regulatory authorities for approval of diagnostic agents.
January 16, 2013 
Feature
The number of students entering radiography educational programs decreased in 2012, according to the latest American Society of Radiologic Technologists (ASRT) Enrollment Snapshot of Radiography, Radiation Therapy and Nuclear Medicine Technology Programs.
January 16, 2013 Sponsored Content
News | Computed Tomography (CT)
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
August 06, 2024 
Feature
The American Medical Association (AMA) submitted formal comments to the Office of the National Coordinator for Health Information Technology (ONC) on the Health IT Policy Committee’s proposal for Stage 3 of the Medicare/Medicaid meaningful use electronic health record (EHR) program requirements.
January 16, 2013 
Technology
Lantheus Medical Imaging Inc. has added a low-enriched uranium (LEU) TechneLite (technetium Tc 99m Generator) generator to the its nuclear imaging product portfolio. Lantheus’ LEU TechneLite generator is the first technetium-99m (Tc-99m) generator in the United States that contains molybdenum-99 (Mo-99) produced from at least 95 percent LEU. With greater access to LEU Mo-99 through its supply chain diversification strategy, Lantheus can now move closer to its goal of eventually eliminating Highly Enriched Uranium (HEU)-sourced Mo-99 from its supply chain. Lantheus’ first LEU TechneLite generator was shipped on Jan. 7, 2013.
January 16, 2013 Sponsored Content
News | Computed Tomography (CT) | August 06, 2024
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
News
DR Systems, a leading independent provider of enterprise-wide medical imaging and information systems, announced that the United States Patent and Trademark Office (USPTO) has issued to the company a new patent, relating to a system and method for viewing medical images at full resolution.
January 15, 2013 Sponsored Content
News | Artificial Intelligence
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
June 21, 2024 
News
Advanced Radiation Therapy (ART), manufacturer of the AccuBoost System for radiation therapy of partial breast and Elekta a global leader in cancer management systems and software, announced today that they have executed an agreement whereby ART acquires the assets of all AccuBoost installations held by Elekta, its worldwide distribution partner. As part of the transaction, ART has purchased the assets and the operating agreements for more than 20 installations in the U.S. The transaction is designed to enable both companies to focus on their core competencies, and serves AccuBoost user groups by allowing ART to increase its support to these installations.
January 15, 2013 
Technology
Viztek, the advanced digital imaging solution provider, has received United States Federal Food and Drug Administration (FDA) 510k clearance for the ViZion + DR line of panels. This new family of products includes multiple panels in tethered, wireless and fixed configurations offering high quality images at quick speeds, while remaining at a competitive price point. Unlike many competing products, the panels have an ease of adaptability and require no generator interface.
January 15, 2013 
Technology
Embrace Thermoplastic is a premium low-melt material used to create customizable immobilization for patients receiving radiation therapy treatments of the head and neck. Embrace Thermoplastic products include Standard UFrames, Versaboard frames, S-Type frames, and Thermoplastic sheets. All Embrace Thermoplastic products are made in the United States.
January 14, 2013 Sponsored Content
Feature | Artificial Intelligence
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
June 03, 2024 
Feature
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the U.S. market for diagnostic imaging equipment servicing will grow slowly to a value of just over $2.78 billion by 2017. Increases in diagnostic imaging system sales and the installed base will be counterbal
January 14, 2013 
Feature
http://glossary.itnonline.com/3d-mammographyHologic Inc. announced that a groundbreaking new study published in Radiology, the Radiological Society of North America scientific journal, found that the addition of three dimensional (3-D) mammography (breast tomosynthesis) screening technology to a 2-D breast screening exam significantly increased cancer detection while reducing the number of false positives.
January 14, 2013 
Feature
January 11, 2013 — New guidelines from the American Cancer Society say there is now sufficient evidence to recommend screening high-risk patients for lung cancer with low-dose computed tomography (LDCT), provided that certain conditions exist.
January 11, 2013 Sponsored Content
Case Study | Enterprise Imaging
Having the most efficient clinical workflows with enhanced diagnostic capabilities is a major goal for clinicians and ...
May 16, 2024 
News
Availability of CT colonography (CTC), commonly known as virtual colonoscopy, is increasing colorectal cancer (CRC) screening rates across military medical facilities. Inclusion of CTC as a Healthcare Effectiveness Data and Information Set (HEDIS)-compliant colorectal cancer (CRC) screening test can potentially raise overall screening rates, according to a study in the January issue of the Journal of the American College of Radiology.
January 11, 2013 
News
In the management of gliomas — or tumors that originate in the brain — precise assessment of tumor grade and the proliferative activity of cells plays a major role in determining the most appropriate treatment and predicting overall survival. Research published in the December issue of The Journal of Nuclear Medicine (JNM) highlights the potential of imaging with 3'-deoxy-3'-F-18-fluorothymidine (F-18-FLT) positron emission tomography (PET) to noninvasively and accurately provide tumor-specific details to guide management of patients with gliomas.
January 11, 2013 Sponsored Content
News | Artificial Intelligence | June 21, 2024
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Feature
According to a new market research report "Breast Imaging Technologies Market (Digital Mammography,3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) Technology and Market Analysis & Global Forecasts to 2017" is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation. Ionizing breast imaging modalities include Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI), Positron Emission Tomography (PET) and Breast Specific Gamma Imaging (BSGI). The various Non-ionizing modalities for breast screening covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.
January 11, 2013 
News
Royal Philips Electronics today announced a landmark agreement with the Farah Medical Complex in Jordan that will see the development of a new hospital which has patient experience firmly at the center of its ethos. Through this partnership, Philips will provide a customized package of 15 advanced imaging solution systems, healthcare informatics and services, in addition to a suite of 20 Ambient Experience rooms, the largest installation to date in any hospital worldwide.
January 10, 2013 News
Bayer HealthCare announced that the company has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA), seeking approval for radium Ra 223 dichloride (radium-223), an investigational compound for the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases.
January 10, 2013 
News
Avreo announced that KLAS, an independently owned and operated healthcare technology research organization, has ranked Avreo interWORKS 1st for Radiology (Community) in the “2012 Best in KLAS Awards: Software & Services” report for the second year in a row. Avreo’s interWORKS product earned a high score of 90.9 out of 100 with a 100 percent of participators saying they would buy the Avreo solution again.
January 10, 2013 
Technology
iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced approval by the U.S. Food and Drug Administration (FDA) for use of the company’s next generation mammography computer-aided detection (CAD) platform, PowerLook Advanced Mammography Platform (AMP), with Digital CAD for Philips’ MicroDose Full-Field Digital Mammography System.
January 10, 2013 
Blog
The radiology community may be in for a shock soon. Regents Health Resources, a national consulting firm specializing in medical imaging business intelligence, suggests that the volume of imaging exams is about to explode. Regents estimates that new coverage under healthcare reform will lead providers to perform millions more exams than in years past. Californians alone could receive almost 9 million additional exams. Across the country, medical imaging procedures are forecast to rise 13.6 percent, which translates into 61 million more procedures annually.
January 10, 2013 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now